What does a urine microalbumin‑creatinine ratio of 138.5 mg/g indicate and how should it be managed?

A urine microalbumin-creatinine ratio of 138.5 mg/g indicates moderately elevated albuminuria (previously termed "microalbuminuria") and requires confirmation testing followed by aggressive cardiovascular and renal risk reduction.

What This Result Means

Your ratio of 138.5 mg/g falls in the moderately elevated albuminuria range (30-300 mg/g) 1. This is not normal (normal is ≤30 mg/g) but has not yet progressed to severely elevated albuminuria (≥300 mg/g) 1, 2.

This finding signals two critical problems:

• Early kidney damage with increased risk of progression to end-stage renal disease
• Significantly elevated cardiovascular risk, including heart attack, stroke, and cardiovascular death 3, 4, 5, 6

The presence of albuminuria at this level reflects generalized vascular dysfunction affecting not just your kidneys but your entire cardiovascular system 6, 7, 8.

Immediate Next Steps: Confirmation Testing

You must confirm this result before making treatment decisions. Because albumin excretion varies day-to-day, guidelines require that 2 of 3 urine samples collected over 3-6 months show elevated levels before confirming persistent albuminuria 1, 9.

Important factors that can falsely elevate results:

• Vigorous exercise within 24 hours before collection
• Urinary tract infection or fever
• Marked hyperglycemia (very high blood sugar)
• Uncontrolled hypertension
• Congestive heart failure
• Menstruation 1, 9

Avoid these factors when collecting repeat samples. First morning urine samples are preferred 1.

Management Once Confirmed

1. Blood Pressure Control (Highest Priority)

Target: <130/80 mmHg 3, 4, 6, 10

Start an ACE inhibitor or ARB (angiotensin receptor blocker) immediately if you have:

• Diabetes with confirmed albuminuria 3, 4, 11
• Hypertension with confirmed albuminuria 10

These medications are specifically recommended because they:

• Reduce albuminuria by ≥30% (which correlates with reduced cardiovascular and kidney events) 12
• Lower intraglomerular pressure
• Provide renoprotection beyond blood pressure lowering alone 7, 10

Do not use ACE inhibitors or ARBs if you are pregnant 4.

2. Glucose Control (If Diabetic)

Target HbA1c: <7% 3, 11, 6

Intensive glucose control has been proven to delay progression from moderately elevated to severely elevated albuminuria in both type 1 and type 2 diabetes 3.

3. Additional Cardiovascular Risk Reduction

• LDL cholesterol: <100 mg/dL (or <120 mg/dL if non-diabetic) 6
• Sodium restriction: <6 g/day 10
• Smoking cessation (smoking accelerates nephropathy) 11, 6, 10
• Weight loss if BMI >30 6

4. Monitoring Strategy

Retest albuminuria within 6 months after starting treatment to assess response 1. Your goal is to:

• Reduce the albumin-creatinine ratio by at least 30% from baseline 12
• Ideally normalize it to <30 mg/g

If albuminuria does not decrease after 6 months:

• Verify blood pressure targets are met
• Confirm you're on maximum tolerated doses of ACE inhibitor or ARB
• Consider adding a thiazide diuretic (synergistic effect with ACE inhibitor/ARB) 10
• Reassess all cardiovascular risk factors 1

If albuminuria improves significantly, continue annual monitoring 1, 4.

5. Assess Kidney Function

Obtain estimated GFR (eGFR) if not already done 4, 13, 2. This determines your CKD stage and guides medication dosing.

Consider nephrology referral if:

• eGFR <60 mL/min/1.73 m² 4, 2
• Rapidly increasing albuminuria
• Active urinary sediment (blood cells or casts)
• Absence of diabetic retinopathy in type 1 diabetes (suggests alternative kidney disease) 2

Key Clinical Pitfall

The most common mistake is failing to act on moderately elevated albuminuria. Many clinicians overlook this finding or delay treatment, but your cardiovascular risk is already substantially elevated at this level 5, 6, 8. Even values within the "normal" range (<30 mg/g) show a continuous relationship with cardiovascular risk, meaning your result of 138.5 mg/g places you at high risk 2, 14.

Bottom line: Confirm with repeat testing, then immediately initiate aggressive blood pressure control (preferably with ACE inhibitor or ARB), optimize glucose control if diabetic, and address all modifiable cardiovascular risk factors. Reducing your albumin-creatinine ratio by ≥30% will translate directly into reduced risk of heart attack, stroke, kidney failure, and death 12.